Houman David Hemmati

Opinion author

Houman David Hemmati is a physician, scientist and rare disease advocate who has worked in clinical medicine, biomedical research and the development of novel therapies for patients with serious and life-threatening conditions. He is currently a medical advisor or board member of several biotherapeutics companies.

FDA’s rare disease decisions are strongest when the patient community has a voice in advisory committee decisions.